Mitogen-activated protein kinase phosphatase-1 promotes neovascularization and angiogenic gene expression
Joel D Boerckel1, Unnikrishnan M Chandrasekharan, Matthew S Waitkus
1From the Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, OH (J.D.B., U.M.C., M.S.W., E.G.T., R.B., P.E.D.); and Department of Aerospace and Mechanical Engineering, University of Notre Dame, IN (J.D.B.).
Objective:
Angiogenesis is the formation of new blood vessels through endothelial cell sprouting. This process requires the mitogen-activated protein kinases, signaling molecules that are negatively regulated by the mitogen-activated protein kinase phosphatase-1 (MKP-1). The purpose of this study was to evaluate the role of MKP-1 in neovascularization in vivo and identify associated mechanisms in endothelial cells.
Approach And Results:
We used murine hindlimb ischemia as a model system to evaluate the role of MKP-1 in angiogenic growth, remodeling, and arteriogenesis in vivo. Genomic deletion of MKP-1 blunted angiogenesis in the distal hindlimb and microvascular arteriogenesis in the proximal hindlimb. In vitro, endothelial MKP-1 depletion/deletion abrogated vascular endothelial growth factor-induced migration and tube formation, and reduced proliferation. These observations establish MKP-1 as a positive mediator of angiogenesis and contrast with the canonical function of MKP-1 as a mitogen-activated protein kinase phosphatase, implying an alternative mechanism for MKP-1-mediated angiogenesis. Cloning and sequencing of MKP-1-bound chromatin identified localization of MKP-1 to exonic DNA of the angiogenic chemokine fractalkine, and MKP-1 depletion reduced histone H3 serine 10 dephosphorylation on this DNA locus and blocked fractalkine expression. In vivo, MKP-1 deletion abrogated ischemia-induced fractalkine expression and macrophage and T-lymphocyte infiltration in distal hindlimbs, whereas fractalkine delivery to ischemic hindlimbs rescued the effect of MKP-1 deletion on neovascular hindlimb recovery.
Conclusions:
MKP-1 promoted angiogenic and arteriogenic neovascular growth, potentially through dephosphorylation of histone H3 serine 10 on coding-region DNA to control transcription of angiogenic genes, such as fractalkine. These observations reveal a novel function for MKP-1 and identify MKP-1 as a potential therapeutic target.
Insights
Mitogen-activated protein kinase phosphatase-1 (MKP-1) promotes new blood vessel formation (angiogenesis) by regulating gene transcription, not just by deactivating signaling molecules. This novel function highlights MKP-1 as a potential therapeutic target for neovascular diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Vascular Biology
Background:
- Angiogenesis, the formation of new blood vessels, is crucial for tissue repair and development.
- Mitogen-activated protein kinases (MAPKs) are key regulators of angiogenesis.
- Mitogen-activated protein kinase phosphatase-1 (MKP-1) typically inhibits MAPK signaling.
Purpose of the Study:
- To investigate the role of MKP-1 in in vivo neovascularization.
- To elucidate the underlying molecular mechanisms of MKP-1 in endothelial cells.
Main Methods:
- Murine hindlimb ischemia model to study angiogenesis and arteriogenesis.
- In vitro endothelial cell assays (migration, tube formation, proliferation) with MKP-1 depletion/deletion.
- Chromatin immunoprecipitation sequencing to identify MKP-1 binding sites.
- Analysis of histone modifications and gene expression (fractalkine).
Main Results:
- MKP-1 deficiency impaired angiogenesis and arteriogenesis in vivo.
- Endothelial MKP-1 is essential for vascular endothelial growth factor-induced cell migration, tube formation, and proliferation.
- MKP-1 directly binds to the fractalkine gene locus, regulating histone H3 serine 10 dephosphorylation and fractalkine expression.
- MKP-1 deletion reduced inflammatory cell infiltration, and fractalkine administration rescued neovascularization in MKP-1-deficient mice.
Conclusions:
- MKP-1 acts as a positive regulator of angiogenic and arteriogenic neovascular growth.
- A novel mechanism involves MKP-1 controlling gene transcription via histone modification.
- MKP-1 represents a potential therapeutic target for promoting neovascularization.
More Related Videos
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
